Trivarx Ltd has released a press release.
Positive Results from Phase 2 SAMDE Study
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Story so far
Earlier from TrivarX
- TrivarX Receives Firm Commitments to Raise $2.5 million
- March 2024 Quarterly Activities Report and Appendix 4C
- Appendix 4D & Half-Year Financial Report to 31 December 2023
- Response to ASX Price Query
- TrivarX Receives $888k R&D Tax Incentive
Later from TrivarX
- June 2024 Quarterly Activities Report and Appendix 4C
- September 2024 Quarterly Activities Report and Appendix 4C
- New AI Tool Expands Patient Reach and Market Opportunities
- TrivarX Receives $1.03m R&D Tax Incentive
- December 2024 Quarterly Activities Report and Appendix 4C
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX